Abstract
Background
Bronchial asthma is an allergic disorder characterized by excessive hyperactive nature of the airways, which depends on many cytokines such as interleukin-4 (IL-4) and IL-5 that are responsible for the allergic inflammatory response. One of the strategies in the management of bronchial asthma is the induction of synthesis of IL-10; it has an inhibitory effect on the synthesis of the T-helper-2 (Th2) cytokines. Th2 cells play a triggering role in the activation/recruitment of immunoglobulin E antibody-producing B cells, mast cells, and eosinophil cells. To assess regulatory changes in the immune system, in patients with allergy and asthma, we studied the cytokine profile in serum in comparison with normal healthy controls. The study was carried out in Allergy and Immunology Unit, Ain Shams University Hospitals. A total of 170 patients with various allergies and asthmatic conditions were studied, for cytokines in the serum by enzyme-linked immunosorbent assay using kits from Immune Technology, and analyzed to identify the triggering factors or main contributors toward allergy and asthma. Our study showed increase in the levels of IL-4, IL-5, and IL-6 in all groups, which was nonsignificant. However, the levels of IL-10, IL-13, and tumor necrosis factor-α were highly significantly increased. Besides, we found correlation of granulocyte macrophage colony-stimulating factor with IL-10. Significant positive correlation with different cytokines was observed. Most of these patients showed increase in immunoglobulin E levels. This study gives a better understanding of how cytokines are the mediators of balance of Th1 and Th2 immune responses and how immunoglobulin E synthesis is controlled by cytokines. Further studies will eventually lead to improved treatment strategies in the clinical management of immunoglobulin E-mediated allergy.
Article PDF
Similar content being viewed by others
References
Lambrecht BN. An unexpected role for the anaphylax toxin C5a receptor in allergic sensitization. J Clin Invest 2006; 116:628–632.
Spahn JD, Leung DY, Szefler SJ. New insights into the pathogenesis and management of steroid resistant asthma. J Asthma 2007; 34:177–194.
Janeway CA, Travers P, Walport M, Shiomchik MJ. Immunobiology. New York: Garland Science; 2005.
Herrick CA, Bottonly K. To respond or not to respond: T cells in allergic asthma. Nat Rev 2003; 3:405–412.
Meyer EH, Goya S, Akbari O, Berry GJ, Savage PB, Kronenberg M, et al. Glycolipid activation of invariant T cell receptor NK T cells is sufficient to induce airway hyper reactivity independent of conventional CD4+ T cells. PNAS 2006; 103:2782–2787.
Lee CG, Kumar S, Griswold DE, Underwood DC. Transgenic over expression of interleukin 10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13 dependent-independent pathways. J Biol Chem 2002; 277:35466–35474.
Tournoy KG, Hove CV, Grooten J, Moerloose K, Brusselle GG, Joos GF. Animal models of allergen induced tolerance in asthma: are T-regulatory-1 cells, the solution for T-helper-2 cells in asthma?. Clin Exp Allergy 2006; 36:8–20.
Akbari O, Stock P, DeKruyff RH, Umetsu DT. Role of regulatory T cells in allergy and asthma. Curr Opin Immunol 2003; 15:627–633.
Chikanza IC. Mechanisms of corticosteroid resistance in rheumatoid arthritis: a putative role for the corticosteroid receptor beta isoform. Ann N Y Acad Sci 2002; 966:39–48.
Mishan-Eisenberg G, Borovsky Z, Weber MC, Gazit R, Tykocinski ML, Rachmilewitz J. Differential regulation of Th1/Th2 cytokine responses by placental protein 14. J Immunol 2004; 173:5524–5530.
Zhou Y, McLane M, Levitt RC. Th2 cytokines and asthma – interleukin-9 as a therapeutic target for asthma. Respir Res 2001; 2:80–84.
Ngoc LP, Gold DR, Tzianabos AO, Weiss ST, Celedon JC. Cytokines, allergy and asthma. Curr Opin Allergy Clin Immunol 2005; 5:161–166.
Malviya AM. Cytokine network and its manipulation in rheumatoid arthritis. J Assoc Physicians India 2006; 54:15–18.
Olsson A, Cagnoni F, Dignetti P, Melioli G, Canonica GW. Low concentration of cytokines produced by allergen-stimulated peripheral blood mononuclear cells have potent effects on nasal polyp-derived fibroblasts. Clin Exp Immunol 2003; 132:254–260.
Bischoff SC, Sellge G. Mast cell hyperplasia: role of cytokines. Int Arch Allergy Immunol 2002; 127:118–122.
Will-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282:2258–2261.
Chung F. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma. Mediators Inflamm 2001; 10:51–59.
Frieri M. Advances in the understanding of allergic asthma. Allergy Asthma Proc 2007; 28:614–619.
Aziz N, Nishanian P, Fahey JL. Levels of cytokines and immune activations markers in plasma in human immunodeficiency virus infection, quality control procedures. J Infect Dis 1998; 5:755–761.
Boyton RJ, Altamann DM. Asthma: new developments in cytokine regulation. Clin Exp Immunol 2004; 136:13–14.
Barnes PJ. Th2 cytokines and asthma: an introduction. Respir Res 2001; 2:64–65.
Hawrylowicz CM, O’Garra A, Richards D. Potential role of IL-10 secreting regulation T cells in allergy and asthma. Nat Rev Immunol 2005; 5:271–283.
Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM. Mitogen activated protein kinase induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid insensitive asthma. JAllergy Clin Immunol 2002; 109:649–657.
Hawrylowicz CM, Richards D, Corrigan C, Lee T. A defect in corticosteroid induced interleukin 10 production in T lymphocytes from corticosteroid resistant asthmatic patients. J Allergy Clin Immunol 2002; 9:369–370.
Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF, et al. Reversing the defective induction of IL-10 secreting regulatory T cells in glucocorticoid resistant asthma patients. J Clin Invest, 2006; 116:146–155.
Centers for Disease Control. Forecasted state specific estimates of self reported asthma prevalence – United States, 2006. MMWR 2006; 47:1022–1025.
Franchimont, D Davenport MG, Garg R. Tumor neurosis factor alpha decreases and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of glucocorticoid receptor. J Clin Endocrinol Metab, 2001; 84:2834–2839.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Attia, M.Y., Saber, H.M. Role played by T-helper 2 in resetting the cytokine balance in allergic patients. Egypt J Intern Med 26, 124–129 (2014). https://doi.org/10.4103/1110-7782.145311
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/1110-7782.145311